Navigation Links
ULURU Inc. Reports Third Quarter 2010 Financial Results
Date:11/15/2010

selling, general and administrative expenses reflects the Company's restructured business plan which contributed to a decrease of $164,000 in administrative compensation, lower legal fees of $134,000, lower legal fees related to our patents of $30,000, lower consulting fees of $28,000, a decrease in travel expenses of $15,000, and a decrease of $13,000 in insurance expense.  These expense decreases were partially offset by an increase in director fees of $64,000, a component of share-based compensation.

Other income and Other expenses

Interest and miscellaneous income for the third quarter of 2010 was $4,800 as compared to $6,700 for the third quarter of 2009.  The decrease of $1,900 is attributable to a decrease in interest income due to lower cash balances and interest yields in 2010.

Interest expense for the third quarter of 2010 was $21,000 as compared to $2,000 for the third quarter of 2009.  Interest expense for the third quarter of 2010 consisted of financing costs for our insurance policies and interest costs associated with regulatory fees.  

About ULURU Inc.:ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex™ Aggregate technology and OraDisc™ transmucosal delivery system. For further information about ULURU Inc., please visit our website at www.uluruinc.com.  For further information about Altrazeal®, please visit our website at www.altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to future financial performance of ULU
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., a ... industry, announced that it is the first CRO on ... the company,s preclinical and early phase clinical GMP supply ... move our customers, drug candidates into the clinic more ...
... The next major personalized medicine advances will create therapies that ... health care industry to gain access, the inventor of the ... Medical Center,s Personalized Health Care National Conference ... for Systems Biology, said personalized medicine,s first "killer apps" - ...
Cached Medicine Technology:Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to ... Reduce Painkiller Overdoses (8/25), a new study found ... reduce pain have seen a significant decrease in the ... information over a ten year period, and comparing various ... able to find that there was about a 25% ...
(Date:8/29/2014)... As reported by WKMS.com in the article ... Ohio municipal court drug has come up with a new ... serves as the presiding judge in a Southeastern Ohio municipal ... addicts a medicated treatment option that can literally prevent them ... as Vivitrol, which blocks receptors in the brain that would ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription Drug ... that you need help for a prescription drug abuse problem ... fact that if you simply try to find general help ... of the information that is available online. Although the information ... still possible to get help. The statistics from SAMSHA remind ...
(Date:8/29/2014)... reported by GantDaily.com in the article NIDA Switches to ... the National Institute on Drug Abuse is taking new measures ... to social media. As NIDA currently relies on community surveillance ... the University of Maryland to create a monitoring system known ... funded by the National Institute of Health. The project is ...
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 According to ... Peers, But Not Peer Pressure, Key to Prescription Drug Misuse ... the primary focus for 18-29 year olds when it comes ... that the for this age group the real problem which ... drugs, drug associations and recreational use of them to have ...
Breaking Medicine News(10 mins):Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3
... NY, October 29, 2010Women experience and interact with their natural ... in which those differences affect a woman,s sense of self, ... are explored in a thought-provoking special issue of ... Liebert, Inc. ( www.liebertpub.com ). The entire issue is available ...
... , FRIDAY, Oct. 29 (HealthDay News) -- Lack ... children with the drug-resistant staph bacteria called MRSA (methicillin-resistant ... staff need to do a better job of educating ... said the researchers at the Johns Hopkins Children Center ...
... YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical ... and Hendra viruses, two lethal and emerging viruses for which ... could also lead to new therapies for measles, mumps and ... the prestigious journal Public Library of Science (PLoS) Pathogens ...
... - A study in the New England Journal of ... kind of lung cancer are responding positively to a treatment ... study shows 57 percent of patients with ALK-positive advanced non-small ... called crizotinib, an investigational anaplastic lymphoma kinase (ALK) inhibitor. In ...
... of Wisconsin are conducting the KAST clinical trial ... effectiveness of a new vertebral augmentation treatment (Kiva) ... osteoporosis. Sean Tutton, M.D, associate ... College, is principal interventional radiology investigator for this ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, Oct. ... the brain,s ability to detect and correct errors, such as ... , Researchers had three groups of 24 skilled typists use ... inserted typographical errors or removed them from the typed text ...
Cached Medicine News:Health News:Women's unique connection to nature is explored in special issue of Ecopsychology 2Health News:Many Parents in the Dark About Drug-Resistant Infections: Study 2Health News:Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers 2Health News:People with specific kind of lung cancer respond to new targeted treatment 2Health News:People with specific kind of lung cancer respond to new targeted treatment 3Health News:National research study to assess new treatment for painful vertebral fractures 2Health News:Brain's Error-Detection System Demystified 2
Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
Inquire...
... II (Low Melt), A low temperature ... melting temperature , Optimal for in-gel restriction ... forms a very manageable clear gel that ... Melts at approximately 65°C and remains fluid ...
... Agarose, Molecular Biology Grade, is ... of nucleic acids. It can ... fragments from 0.2 to 40 ... Agarose is tested and certified ...
Medicine Products: